Effect of buspirone, fluoxetine and 8-OH-DPAT on striatal expression of bax, caspase-3 and Bcl-2 proteins in 6-hydroxydopamine-induced hemi-parkinsonian rats

Advanced Pharmaceutical Bulletin

Volumn 5, Issue 4, 2015, Pages 491-495

  Sharifi, Hamdollah ^a   Nayebi, Alireza Mohajjel ^b,c   Farajnia, Safar ^b   Haddadi, Rasool ^d  

^a URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

8 OH DPAT; Apoptosis; Buspirone; Fluoxetine; Parkinson's disease

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; BUSPIRONE; CASPASE 3; FLUOXETINE; OXIDOPAMINE; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; ENZYME ACTIVITY; LONG TERM CARE; MALE; NONHUMAN; PARKINSONISM; PROTEIN EXPRESSION; RAT; SUBSTANTIA NIGRA PARS COMPACTA;

EID: 84949651815     PISSN: 22285881     EISSN: 22517308     Source Type: Journal    
DOI: 10.15171/apb.2015.067     Document Type: Article

References (32)

1. Nagatsu T. Parkinson's disease: Changes in apoptosis-related factors suggesting possible gene therapy. J Neural Transm 2002;109(5-6):731-45. doi: 10.1007/s007020200061
2. Double KL, Reyes S, Werry EL, Halliday GM. Selective cell death in neurodegeneration: Why are some neurons spared in vulnerable regions? Prog Neurobiol 2010;92(3):316-29. doi: 10.1016/j.pneurobio.2010.06.001
3. Singh S, Dikshit M. Apoptotic neuronal death in parkinson's disease: Involvement of nitric oxide. Brain Res Rev 2007;54(2):233-50. doi: 10.1016/j.brainresrev.2007.02.001
4. Zaldana M, Bonastre M, Aguilar E, Marin C. Differential nigral expression of bcl-2 protein family in chronically haloperidol and clozapine-treated rats: Role in neurotoxicity and stereotyped behavior. Exp Neurol 2007;203(2):302-8. doi: 10.1016/j.expneurol.2006.08.009
5. Hartmann A, Troadec JD, Hunot S, Kikly K, Faucheux BA, Mouatt-Prigent A, et al. Caspase-8 is an effector in apoptotic death of dopaminergic neurons in parkinson's disease, but pathway inhibition results in neuronal necrosis. J Neurosci 2001;21(7):2247-55.
6. Hartmann A, Mouatt-Prigent A, Vila M, Abbas N, Perier C, Faucheux BA, et al. Increased expression and redistribution of the antiapoptotic molecule bcl-xl in parkinson's disease. Neurobiol Dis 2002;10(1):28-32.
7. Kramer BC, Mytilineou C. Alterations in the cellular distribution of bcl-2, bcl-x and bax in the adult rat substantia nigra following striatal 6-hydroxydopamine lesions. J Neurocytol 2004;33(2):213-23.
8. Oosterink BJ, Harkany T, Luiten PG. Post-lesion administration of 5-ht1a receptor agonist 8-oh-dpat protects cholinergic nucleus basalis neurons against nmda excitotoxicity. Neuroreport 2003;14(1):57-60. doi: 10.1097/01.wnr.0000051543.96524.3c
9. Ahlemeyer B, Glaser A, Schaper C, Semkova I, Krieglstein J. The 5-ht1a receptor agonist bay x 3702 inhibits apoptosis induced by serum deprivation in cultured neurons. Eur J Pharmacol 1999;370(2):211-6.
10. Sharifi H, Nayebi AM, Farajnia S. Chronic administration of 8-OH-DPAT attenuates catlepsy in 6-hydroxydopamine-lesioned rats through modulation of inflammatory cytokines. Iran J Basic Med Sci 2013;16(12):1270-75.
11. Sharifi H, Mohajjel Nayebia A, Farajnia S. Dose-dependent effect of flouxetine on 6-ohda-induced catalepsy in male rats: A possible involvement of 5-ht1a receptors. Advanced pharmaceutical bulletin 2013;3(1):203-6. doi: 10.5681/apb.2013.033
12. Sharifi H, Mohajjel Nayebia A, Farajnia S. The effect of chronic administration of buspirone on 6-hydroxydopamine-induced catalepsy in rats. Adv Pharm Bull 2012;2(1):127-31. doi: 10.5681/apb.2012.019
13. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 6th ed. Sydney: Academic Press; 1982.
14. Mahmoudi J, Mohajjel Nayebi A, Reyhani-Rad S, Samini M. Fluoxetine improves the effect of levodopa on 6-hydroxy dopamine-induced motor impairments in rats. Adv Pharm Bull 2012;2(2):149-55. doi: 10.5681/apb.2012.023
15. Javad Mahmoudi, Alireza Mohajjel Nayebi, Morteza Samini, Siamak Reyhani-Rad, Vahab Babapour. Buspirone improves the anti-cataleptic effect of levodopa in 6-hydroxydopamine-lesioned rats. Pharmacolo Rep 2011; 63 (4): 908-914.
16. Mahmoudi J, Mohajjel Nayebi A, Samini M, Reyhani-Rad S, Babapour V. 5-ht(1a) receptor activation improves anti-cataleptic effects of levodopa in 6-hydroxydopamine-lesioned rats. Daru 2011;19(5):338-43.
17. Nayebi AM. Hypothesis: A promising effect of 5-HT1A receptor agonists in alleviating motor symptoms of Parkinsons disease. Afr J Pharm Pharmaco 2010;4(6):289-90.
18. Levy OA, Malagelada C, Greene LA. Cell death pathways in parkinson's disease: Proximal triggers, distal effectors, and final steps. Apoptosis 2009;14(4):478-500. doi: 10.1007/s10495-008-0309-3
19. Ayllon V, Cayla X, Garcia A, Roncal F, Fernandez R, Albar JP, et al. Bcl-2 targets protein phosphatase 1 alpha to bad. J Immunol 2001;166(12):7345-52.
20. Djordjevic A, Djordjevic J, Elakovic I, Adzic M, Matic G, Radojcic MB. Fluoxetine affects hippocampal plasticity, apoptosis and depressive-like behavior of chronically isolated rats. Prog Neuropsychopharmacol Biol Psychiatry 2012;36(1):92-100. doi: 10.1016/j.pnpbp.2011.10.006
21. Yuan J, Yankner BA. Apoptosis in the nervous system. Nature 2000;407(6805):802-9. doi: 10.1038/35037739
22. Becker EB, Bonni A. Cell cycle regulation of neuronal apoptosis in development and disease. Prog Neurobiol 2004;72(1):1-25. doi: 10.1016/j.pneurobio.2003.12.005
23. Han BS, Hong HS, Choi WS, Markelonis GJ, Oh TH, Oh YJ. Caspase-dependent and -independent cell death pathways in primary cultures of mesencephalic dopaminergic neurons after neurotoxin treatment. J Neurosci 2003;23(12):5069-78.
24. Charkhpour M, Nayebi AR, Doustar Y, Hassanzadeh K. 8-oh-dpat prevents morphine-induced apoptosis in rat dorsal raphe nucleus: A possible mechanism for attenuating morphine tolerance. Anesth Analg 2010;111(5):1316-21. doi: 10.1213/ANE.0b013e3181f1bb9a
25. Mattson MP. Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol 2000;1(2):120-9. doi: 10.1038/35040009
26. Guo DJ, Li F, Yu PH, Chan SW. Neuroprotective effects of luteolin against apoptosis induced by 6-hydroxydopamine on rat pheochromocytoma pc12 cells. Pharm Biol 2013;51(2):190-6. doi: 10.3109/13880209.2012.716852
27. Berends AC, Luiten PG, Nyakas C. A review of the neuroprotective properties of the 5-ht1a receptor agonist repinotan hcl (bayx3702) in ischemic stroke. CNS drug reviews 2005;11(4):379-402.
28. Ohman J, Braakman R, Legout V, Traumatic Brain Injury Study G. Repinotan (bay x 3702): A 5ht1a agonist in traumatically brain injured patients. J Neurotrauma 2001;18(12):1313-21. doi: 10.1089/08977150152725614
29. Meller E. 5-ht1a receptor-mediated apoptosis: Death by jnk? Biochim Biophys Acta 2007;1773(6):691-3. doi: 10.1016/j.bbamcr.2007.01.003
30. Cowen DS, Johnson-Farley NN, Travkina T. 5-ht receptors couple to activation of akt, but not extracellular-regulated kinase (erk), in cultured hippocampal neurons. J Neurochem 2005;93(4):910-7. doi: 10.1111/j.1471-4159.2005.03107.x
31. Kukley M, Schaper C, Becker A, Rose K, Krieglstein J. Effect of 5- hydroxytryptamine 1A receptor agonist BAY X 3702 on BCL-2 and BAX proteins level in the ipsilateral cerebral cortex of rats after transient focal ischemia. Neuroscience 2001;107(3):405-13.
32. Adayev T, Ray I, Sondhi R, Sobocki T, Banerjee P. The g protein-coupled 5-ht1a receptor causes suppression of caspase-3 through mapk and protein kinase calpha. Biochim Biophys Acta 2003;1640(1):85-96.